Synapse - Nancy Kemeny

Results (545)

Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)

Meeting Abstract

Weeks, J. C.; Romanus, D.; Herndon, J. E.; Schrag, D.; Mayer, R. J.; Kemeny, N.
Value in Health (2005)

Robustness of response: A new measure of response assessment: Its impact on metricies of response in colorectal cancer

Meeting Abstract

Wang, L.; Schwartz, L. H.; Mazumdar, M.; Smith, A.; Kemeny, N. E.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Meeting Abstract

Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A comparative assessment of the incidence of steatohepatitis seen with modern chemotherapy

Meeting Abstract

Leonard, G. D.; Curran, S. D.; Kemeny, N. E.; Schwartz, L. H.; Fong, Y.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Phase I trial of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic oxaliplatin (OXAL), fluorouracil (FU) plus loucovorin (LV) after resection of hepatic metastases from colorectal cancer

Meeting Abstract

Kemeny, N. E.; Jarnagin, W.; Gonen, M.; Haviland, D.; D'Angelica, M.; Blumgart, L.; DeMatteo, R.; Schwartz, L.; Fong, Y.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Results of a phase I, dose-escalating study of the safety, tolerability and anti-tumor activity of a single injection of a genetically engineered herpes simplex virus, NV1020, in subjects with hepatic colorectal metastases

Meeting Abstract

Kemeny, N.; Jarnagin, W.; Guilfoyle, B.; Tufaro, F.; Karrasch, M.; Mescheder, A.; Ries, S.; Haag, N.; Fong, Y.
Annals of Oncology (2005)

Fulltext@MSK | Save

Hepatic arterial infusion (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response

Meeting Abstract

Danso, M.; Jarnagin, W. R.; Muruganandham, M.; Schwartz, L. H.; Gonen, M.; Haviland, D.; Blumgart, L.; D'Angelica, M.; DeMatteo, R.; Kemeny, N.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Drg1 expression in 131 colorectal liver metastases: Correlation with clinical variables and patient outcomes

Journal Article

Shah, M. A.; Kemeny, N.; Hummer, A.; Drobnjak, M.; Motwani, M.; Cordon-Cardo, C.; Gonen, M.; Schwartz, G. K.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Metastases to the breast from primary pancreatic cancer

Journal Article

Leonard, G. D.; Shia, J.; Kemeny, N. E.
Breast Journal (2005)

Fulltext@MSK | Save

Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma

Journal Article

Leonard, G. D.; Brenner, B.; Kemeny, N. E.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save